Intermittent Hypoxia and Hypercapnia, a Hallmark of Obstructive Sleep Apnea, Alters the Gut Microbiome and Metabolome

ABSTRACT Obstructive sleep apnea (OSA) is a common disorder characterized by episodic obstruction to breathing due to upper airway collapse during sleep. Because of the episodic airway obstruction, intermittently low O2 (hypoxia) and high CO2 (hypercapnia) ensue. OSA has been associated with adverse...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Anupriya Tripathi, Alexey V. Melnik, Jin Xue, Orit Poulsen, Michael J. Meehan, Gregory Humphrey, Lingjing Jiang, Gail Ackermann, Daniel McDonald, Dan Zhou, Rob Knight, Pieter C. Dorrestein, Gabriel G. Haddad
Formato: article
Lenguaje:EN
Publicado: American Society for Microbiology 2018
Materias:
Acceso en línea:https://doaj.org/article/c01326f5b4b0417ba6d9d3532c83605c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:c01326f5b4b0417ba6d9d3532c83605c
record_format dspace
spelling oai:doaj.org-article:c01326f5b4b0417ba6d9d3532c83605c2021-12-02T18:15:44ZIntermittent Hypoxia and Hypercapnia, a Hallmark of Obstructive Sleep Apnea, Alters the Gut Microbiome and Metabolome10.1128/mSystems.00020-182379-5077https://doaj.org/article/c01326f5b4b0417ba6d9d3532c83605c2018-06-01T00:00:00Zhttps://journals.asm.org/doi/10.1128/mSystems.00020-18https://doaj.org/toc/2379-5077ABSTRACT Obstructive sleep apnea (OSA) is a common disorder characterized by episodic obstruction to breathing due to upper airway collapse during sleep. Because of the episodic airway obstruction, intermittently low O2 (hypoxia) and high CO2 (hypercapnia) ensue. OSA has been associated with adverse cardiovascular and metabolic outcomes, although data regarding potential causal pathways are still evolving. As changes in inspired O2 and CO2 can affect the ecology of the gut microbiota and the microbiota has been shown to contribute to various cardiometabolic disorders, we hypothesized that OSA alters the gut ecosystem, which, in turn, exacerbates the downstream physiological consequences. Here, we model human OSA and its cardiovascular consequence using Ldlr−/− mice fed a high-fat diet and exposed to intermittent hypoxia and hypercapnia (IHH). The gut microbiome and metabolome were characterized longitudinally (using 16S rRNA amplicon sequencing and untargeted liquid chromatography-tandem mass spectrometry [LC-MS/MS]) and seen to covary during IHH. Joint analysis of microbiome and metabolome data revealed marked compositional changes in both microbial (>10%, most remarkably in Clostridia) and molecular (>22%) species in the gut. Moreover, molecules that altered in abundance included microbe-dependent bile acids, enterolignans, and fatty acids, highlighting the impact of IHH on host-commensal organism cometabolism in the gut. Thus, we present the first evidence that IHH perturbs the gut microbiome functionally, setting the stage for understanding its involvement in cardiometabolic disorders. IMPORTANCE Intestinal dysbiosis mediates various cardiovascular diseases comorbid with OSA. To understand the role of dysbiosis in cardiovascular and metabolic disease caused by OSA, we systematically study the effect of intermittent hypoxic/hypercapnic stress (IHH, mimicking OSA) on gut microbes in an animal model. We take advantage of a longitudinal study design and paired omics to investigate the microbial and molecular dynamics in the gut to ascertain the contribution of microbes on intestinal metabolism in IHH. We observe microbe-dependent changes in the gut metabolome that will guide future research on unrecognized mechanistic links between gut microbes and comorbidities of OSA. Additionally, we highlight novel and noninvasive biomarkers for OSA-linked cardiovascular and metabolic disorders.Anupriya TripathiAlexey V. MelnikJin XueOrit PoulsenMichael J. MeehanGregory HumphreyLingjing JiangGail AckermannDaniel McDonaldDan ZhouRob KnightPieter C. DorresteinGabriel G. HaddadAmerican Society for Microbiologyarticlecardiovascularmetabolismmicrobiomesleep apneaMicrobiologyQR1-502ENmSystems, Vol 3, Iss 3 (2018)
institution DOAJ
collection DOAJ
language EN
topic cardiovascular
metabolism
microbiome
sleep apnea
Microbiology
QR1-502
spellingShingle cardiovascular
metabolism
microbiome
sleep apnea
Microbiology
QR1-502
Anupriya Tripathi
Alexey V. Melnik
Jin Xue
Orit Poulsen
Michael J. Meehan
Gregory Humphrey
Lingjing Jiang
Gail Ackermann
Daniel McDonald
Dan Zhou
Rob Knight
Pieter C. Dorrestein
Gabriel G. Haddad
Intermittent Hypoxia and Hypercapnia, a Hallmark of Obstructive Sleep Apnea, Alters the Gut Microbiome and Metabolome
description ABSTRACT Obstructive sleep apnea (OSA) is a common disorder characterized by episodic obstruction to breathing due to upper airway collapse during sleep. Because of the episodic airway obstruction, intermittently low O2 (hypoxia) and high CO2 (hypercapnia) ensue. OSA has been associated with adverse cardiovascular and metabolic outcomes, although data regarding potential causal pathways are still evolving. As changes in inspired O2 and CO2 can affect the ecology of the gut microbiota and the microbiota has been shown to contribute to various cardiometabolic disorders, we hypothesized that OSA alters the gut ecosystem, which, in turn, exacerbates the downstream physiological consequences. Here, we model human OSA and its cardiovascular consequence using Ldlr−/− mice fed a high-fat diet and exposed to intermittent hypoxia and hypercapnia (IHH). The gut microbiome and metabolome were characterized longitudinally (using 16S rRNA amplicon sequencing and untargeted liquid chromatography-tandem mass spectrometry [LC-MS/MS]) and seen to covary during IHH. Joint analysis of microbiome and metabolome data revealed marked compositional changes in both microbial (>10%, most remarkably in Clostridia) and molecular (>22%) species in the gut. Moreover, molecules that altered in abundance included microbe-dependent bile acids, enterolignans, and fatty acids, highlighting the impact of IHH on host-commensal organism cometabolism in the gut. Thus, we present the first evidence that IHH perturbs the gut microbiome functionally, setting the stage for understanding its involvement in cardiometabolic disorders. IMPORTANCE Intestinal dysbiosis mediates various cardiovascular diseases comorbid with OSA. To understand the role of dysbiosis in cardiovascular and metabolic disease caused by OSA, we systematically study the effect of intermittent hypoxic/hypercapnic stress (IHH, mimicking OSA) on gut microbes in an animal model. We take advantage of a longitudinal study design and paired omics to investigate the microbial and molecular dynamics in the gut to ascertain the contribution of microbes on intestinal metabolism in IHH. We observe microbe-dependent changes in the gut metabolome that will guide future research on unrecognized mechanistic links between gut microbes and comorbidities of OSA. Additionally, we highlight novel and noninvasive biomarkers for OSA-linked cardiovascular and metabolic disorders.
format article
author Anupriya Tripathi
Alexey V. Melnik
Jin Xue
Orit Poulsen
Michael J. Meehan
Gregory Humphrey
Lingjing Jiang
Gail Ackermann
Daniel McDonald
Dan Zhou
Rob Knight
Pieter C. Dorrestein
Gabriel G. Haddad
author_facet Anupriya Tripathi
Alexey V. Melnik
Jin Xue
Orit Poulsen
Michael J. Meehan
Gregory Humphrey
Lingjing Jiang
Gail Ackermann
Daniel McDonald
Dan Zhou
Rob Knight
Pieter C. Dorrestein
Gabriel G. Haddad
author_sort Anupriya Tripathi
title Intermittent Hypoxia and Hypercapnia, a Hallmark of Obstructive Sleep Apnea, Alters the Gut Microbiome and Metabolome
title_short Intermittent Hypoxia and Hypercapnia, a Hallmark of Obstructive Sleep Apnea, Alters the Gut Microbiome and Metabolome
title_full Intermittent Hypoxia and Hypercapnia, a Hallmark of Obstructive Sleep Apnea, Alters the Gut Microbiome and Metabolome
title_fullStr Intermittent Hypoxia and Hypercapnia, a Hallmark of Obstructive Sleep Apnea, Alters the Gut Microbiome and Metabolome
title_full_unstemmed Intermittent Hypoxia and Hypercapnia, a Hallmark of Obstructive Sleep Apnea, Alters the Gut Microbiome and Metabolome
title_sort intermittent hypoxia and hypercapnia, a hallmark of obstructive sleep apnea, alters the gut microbiome and metabolome
publisher American Society for Microbiology
publishDate 2018
url https://doaj.org/article/c01326f5b4b0417ba6d9d3532c83605c
work_keys_str_mv AT anupriyatripathi intermittenthypoxiaandhypercapniaahallmarkofobstructivesleepapneaaltersthegutmicrobiomeandmetabolome
AT alexeyvmelnik intermittenthypoxiaandhypercapniaahallmarkofobstructivesleepapneaaltersthegutmicrobiomeandmetabolome
AT jinxue intermittenthypoxiaandhypercapniaahallmarkofobstructivesleepapneaaltersthegutmicrobiomeandmetabolome
AT oritpoulsen intermittenthypoxiaandhypercapniaahallmarkofobstructivesleepapneaaltersthegutmicrobiomeandmetabolome
AT michaeljmeehan intermittenthypoxiaandhypercapniaahallmarkofobstructivesleepapneaaltersthegutmicrobiomeandmetabolome
AT gregoryhumphrey intermittenthypoxiaandhypercapniaahallmarkofobstructivesleepapneaaltersthegutmicrobiomeandmetabolome
AT lingjingjiang intermittenthypoxiaandhypercapniaahallmarkofobstructivesleepapneaaltersthegutmicrobiomeandmetabolome
AT gailackermann intermittenthypoxiaandhypercapniaahallmarkofobstructivesleepapneaaltersthegutmicrobiomeandmetabolome
AT danielmcdonald intermittenthypoxiaandhypercapniaahallmarkofobstructivesleepapneaaltersthegutmicrobiomeandmetabolome
AT danzhou intermittenthypoxiaandhypercapniaahallmarkofobstructivesleepapneaaltersthegutmicrobiomeandmetabolome
AT robknight intermittenthypoxiaandhypercapniaahallmarkofobstructivesleepapneaaltersthegutmicrobiomeandmetabolome
AT pietercdorrestein intermittenthypoxiaandhypercapniaahallmarkofobstructivesleepapneaaltersthegutmicrobiomeandmetabolome
AT gabrielghaddad intermittenthypoxiaandhypercapniaahallmarkofobstructivesleepapneaaltersthegutmicrobiomeandmetabolome
_version_ 1718378358485549056